The PromarkerEso diagnostic blood test is intended for early detection and treatment of EAC, a form of oesophageal cancer.

UK-based startup Vicebio has raised $100m to advance its “next-generation vaccines” for respiratory illnesses, including ...

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

It's composed of molecules called glycoproteins that circulate in the blood of the fishes, slightly lowering the temperature at which their body fluids would otherwise freeze and kill them.

Skin-secreted adhesives, or glues, are highly effective defense adaptations that have evolved recurrently in a small number ...

Reformulated flu and COVID-19 shots are available to Oregonians starting this month. And an RSV vaccine — developed only last ...

A variety of molecules protrude from the cell surface, including glycoproteins, glycolipids, and the newly discovered glycoRNAs. This illustration depicts RNA as a double-stranded stem and a loop ...

Financing led by new investor TCGX, alongside Goldman Sachs Alternatives, Avoro Ventures and venBio Funding will support and accelerate development of next-generation multivalent ...

This review highlights the potential of lipidomic and metabolomic biomarkers in predicting breast cancer prognosis and ...

A Phase III study comparing tusamitamab ravtansine with docetaxel in patients with advanced non-squamous non-small cell lung ...